Trial intelligence / Profile preview

Budesonide Maintenance in Collagenous Colitis

NCT00180076Phase 3Completed

Sponsor
Technische Universität Dresden
Start
Jul 2004
Primary completion
Mar 2007
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in collagenous colitis (CC) comparing Budesonide Maintenance with Placebo Maintenance (2 arms). Primary endpoint: Proportion of patients in clinical remission at 6 months. Started Jul 2004; status: completed.

02

Drugs

budesonide
03

Conditions

collagenous colitis (CC)

Beyond the preview

Go deeper on NCT00180076.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00180076.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call